Patent · US Active

mTOR inhibitor salt forms

US8557814B2 · kind B2 · utility

3Cited by
3References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 18, 2009
Grant dateOct 15, 2013
Priority date—
Expiry dateJul 31, 2029

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P35/00
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Salt forms of mTOR inhibitors of the Formula (I):and methods of preparation, formulation, and use in treating disease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.